JUBILANT PHARMOVA
Back to Balance Sheet
|
JUBILANT PHARMOVA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹4,006 Cr | ₹3,765 Cr | ₹2,922 Cr | ₹2,973 Cr | ₹4,088 Cr |
What is the latest Total Non-Current Liabilities ratio of JUBILANT PHARMOVA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹4,006 Cr |
Mar2023 | ₹3,765 Cr |
Mar2022 | ₹2,922 Cr |
Mar2021 | ₹2,973 Cr |
Mar2020 | ₹4,088 Cr |
How is Total Non-Current Liabilities of JUBILANT PHARMOVA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4,006 Cr | 6.39 | |
Mar2023 | ₹3,765 Cr | 28.87 | |
Mar2022 | ₹2,922 Cr | -1.73 | |
Mar2021 | ₹2,973 Cr | -27.27 | |
Mar2020 | ₹4,088 Cr | - |
Compare Total Non-Current Liabilities of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹18,758.4 Cr | -3.7% | -0.1% | 62.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | -3.7% |
-0.1% |
62.6% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses